Back

Impact of different infusion routes in STEMI patients with high thrombotic risk

20 February 2026 (08:30 - 09:30)
Organised by: Logo
Congress Presentation Part of: Contemporary PCI strategies in acute coronary syndromes: from diagnosis to optimisation No Reflow EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Hasan Tokdil

Koc University Hospital, Istanbul (Turkiye)

4 More presentations in this session

Presentation thumbnail
Differences in high-sensitivity troponin assay and association with myocardial injury and periprocedural MI after PCI for de novo three-vessel disease: insights from Multivessel TALENT
Doctor N. Kanehama (Galway, IE)
Abstract Slides
Presentation thumbnail
Cross-sectional analysis of primary PCI provision and AMI mortality across europe: accounting for economic and disease burden
Mr A. Malik (London, GB)
Abstract Slides
Presentation thumbnail
Breaking stereotypes: baseline features, treatment strategies, and 12-month outcomes in SCAD AMI patients: findings from the Serbian SCAD registry (SR SCAD)
Professor S. Apostolovic (Nis, RS)
Abstract Slides
Presentation thumbnail
Intracoronary vasoactive therapy for no-reflow during primary PCI
Doctor F. Oliveri (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Contemporary PCI strategies in acute coronary syndromes: from diagnosis to optimisation

The Event

Event poster

EAPCI Summit 2026

20 February 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
27 August 2022
thumbnail
Congress Presentation
Clinical factors associated with microvascular obstruction in early presenters of ST-segment elevation myocardial infarction
28 August 2020
thumbnail
Congress Presentation
Fractalkine Inhibition in Acute Myocardial Infarction leads to reduced intramyocardial haemorrhage
1 September 2024
thumbnail
Congress Presentation
Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources